A Closer Look at Bristol-Myers Squibb's Options Market Dynamics
A Closer Look at Bristol-Myers Squibb's Options Market Dynamics
Financial giants have made a conspicuous bearish move on Bristol-Myers Squibb. Our analysis of options history for Bristol-Myers Squibb (NYSE:BMY) revealed 9 unusual trades.
金融巨頭對百時美施貴寶採取了明顯的看跌舉動。我們對百時美施貴寶（紐約證券交易所代碼：BMY）期權歷史的分析顯示了9筆不尋常的交易。
Delving into the details, we found 33% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $545,670, and 5 were calls, valued at $215,825.
深入研究細節，我們發現33％的交易者看漲，而66％的交易者表現出看跌傾向。在我們發現的所有交易中，有4筆是看跌期權，價值爲545,670美元，5筆是看漲期權，價值215,825美元。
What's The Price Target?
目標價格是多少？
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $35.0 to $52.5 for Bristol-Myers Squibb during the past quarter.
分析這些合約的交易量和未平倉合約，看來大型企業一直在關注百時美施貴寶在過去一個季度的價格範圍從35.0美元到52.5美元不等。
Analyzing Volume & Open Interest
分析交易量和未平倉合約
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Bristol-Myers Squibb's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Bristol-Myers Squibb's significant trades, within a strike price range of $35.0 to $52.5, over the past month.
檢查交易量和未平倉合約爲股票研究提供了至關重要的見解。這些信息是衡量百時美施貴寶期權在特定行使價下的流動性和利息水平的關鍵。下面，我們將簡要介紹過去一個月百時美施貴寶重大交易的看漲期權和未平倉合約的趨勢，行使價區間爲35.0美元至52.5美元。
Bristol-Myers Squibb 30-Day Option Volume & Interest Snapshot
百時美施貴寶 30 天期權交易量和利息快照
Significant Options Trades Detected:
檢測到的重要期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | PUT | TRADE | BULLISH | 05/16/25 | $2.65 | $2.52 | $2.53 | $40.00 | $227.7K | 124 | 900 |
| BMY | PUT | SWEEP | BEARISH | 09/20/24 | $5.05 | $4.95 | $5.05 | $48.00 | $137.7K | 1.9K | 1 |
| BMY | PUT | SWEEP | BEARISH | 10/18/24 | $8.9 | $8.8 | $8.9 | $52.50 | $117.4K | 696 | 160 |
| BMY | CALL | SWEEP | BULLISH | 01/16/26 | $11.5 | $11.45 | $11.5 | $35.00 | $95.4K | 82 | 0 |
| BMY | PUT | SWEEP | BEARISH | 10/18/24 | $6.75 | $6.65 | $6.75 | $50.00 | $62.7K | 762 | 122 |
| 符號 | 看跌/看漲 | 交易類型 | 情緒 | Exp。日期 | 問 | 出價 | 價格 | 行使價 | 總交易價格 | 未平倉合約 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | 放 | 貿易 | 看漲 | 05/16/25 | 2.65 美元 | 2.52 美元 | 2.53 美元 | 40.00 美元 | 227.7 萬美元 | 124 | 900 |
| BMY | 放 | 掃 | 粗魯的 | 09/20/24 | 5.05 美元 | 4.95 美元 | 5.05 美元 | 48.00 美元 | 137.7 萬美元 | 1.9K | 1 |
| BMY | 放 | 掃 | 粗魯的 | 10/18/24 | 8.9 美元 | 8.8 美元 | 8.9 美元 | 52.50 美元 | 117.4 萬美元 | 696 | 160 |
| BMY | 打電話 | 掃 | 看漲 | 01/16/26 | 11.5 美元 | 11.45 美元 | 11.5 美元 | 35.00 美元 | 95.4 萬美元 | 82 | 0 |
| BMY | 放 | 掃 | 粗魯的 | 10/18/24 | 6.75 美元 | 6.65 美元 | 6.75 美元 | 50.00 美元 | 62.7 萬美元 | 762 | 122 |
About Bristol-Myers Squibb
關於百時美施貴寶
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
百時美施貴寶發現、開發和銷售用於心血管、癌症和免疫疾病等各種治療領域的藥物。布里斯托爾的重點是免疫腫瘤學，該公司是該領域的藥物開發領導者。布里斯托爾將近70％的總銷售額來自美國，這表明其對美國市場的依賴程度高於大多數同行。
Following our analysis of the options activities associated with Bristol-Myers Squibb, we pivot to a closer look at the company's own performance.
在分析了與百時美施貴寶相關的期權活動之後，我們將轉向仔細研究公司自身的表現。
Bristol-Myers Squibb's Current Market Status
百時美施貴寶目前的市場地位
- Currently trading with a volume of 4,006,882, the BMY's price is down by -0.38%, now at $44.47.
- RSI readings suggest the stock is currently may be oversold.
- Anticipated earnings release is in 86 days.
- BMY目前的交易量爲4,006,882美元，價格下跌了-0.38％，目前爲44.47美元。
- RSI讀數表明該股目前可能已超賣。
- 預計收益將在86天后發佈。
What The Experts Say On Bristol-Myers Squibb
專家對百時美施貴寶的看法
3 market experts have recently issued ratings for this stock, with a consensus target price of $47.666666666666664.
3位市場專家最近發佈了該股的評級，共識目標價爲47.6666666666664美元。
- Maintaining their stance, an analyst from Wells Fargo continues to hold a Equal-Weight rating for Bristol-Myers Squibb, targeting a price of $52.
- Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Bristol-Myers Squibb with a target price of $43.
- Consistent in their evaluation, an analyst from BMO Capital keeps a Market Perform rating on Bristol-Myers Squibb with a target price of $48.
- 富國銀行的一位分析師保持立場，繼續對百時美施貴寶維持同等權重評級，目標價格爲52美元。
- 巴克萊銀行的一位分析師在評估中保持對百時美施貴寶的同等權重評級，目標價爲43美元。
- BMO Capital的一位分析師在評估中保持了對百時美施貴寶的市場表現評級，目標價爲48美元。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Bristol-Myers Squibb with Benzinga Pro for real-time alerts.
交易期權涉及更大的風險，但也提供了更高利潤的潛力。精明的交易者通過持續的教育、戰略貿易調整、利用各種指標以及隨時關注市場動態來降低這些風險。使用 Benzinga Pro 了解百時美施貴寶的最新期權交易，獲取實時提醒。
譯文內容由第三人軟體翻譯。